These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 2183712)

  • 1. Paradoxical activity of beta-lactam antibiotics against Proteus vulgaris in experimental infection in mice.
    Ikeda Y; Fukuoka Y; Motomura K; Yasuda T; Nishino T
    Antimicrob Agents Chemother; 1990 Jan; 34(1):94-7. PubMed ID: 2183712
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Paradoxical antibacterial activity of cefmenoxime against Proteus vulgaris.
    Ikeda Y; Nishino T; Tanino T
    Antimicrob Agents Chemother; 1987 Jun; 31(6):865-9. PubMed ID: 3304155
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Paradoxical antibacterial activities of beta-lactams against Proteus vulgaris: mechanism of the paradoxical effect.
    Ikeda Y; Nishino T
    Antimicrob Agents Chemother; 1988 Jul; 32(7):1073-7. PubMed ID: 3056246
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Beta-lactamase stability and antibacterial activity of cefmenoxime (SCE-1365), a novel cephalosporin.
    Okonogi K; Kuno M; Kida M; Mitsuhashi S
    Antimicrob Agents Chemother; 1981 Aug; 20(2):171-5. PubMed ID: 6269488
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reduction of cephamycin concentrations at the infection site in mice with experimental peritoneal infection caused by cephalosporinase-producing bacteria.
    Minami S; Araki H; Watanabe Y; Yasuda T; Takai A; Saikawa I; Mitsuhashi S
    Antimicrob Agents Chemother; 1986 Feb; 29(2):376-8. PubMed ID: 3521482
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chromosomal beta-lactamase expression and resistance to beta-lactam antibiotics in Proteus vulgaris and Morganella morganii.
    Yang YJ; Livermore DM
    Antimicrob Agents Chemother; 1988 Sep; 32(9):1385-91. PubMed ID: 3058021
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro activity and beta-lactamase stability of cefmenoxime.
    Neu HC; Labthavikul P
    Antimicrob Agents Chemother; 1982 Aug; 22(2):316-22. PubMed ID: 6100427
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antimicrobial profiling and molecular characterization of antibiotic resistant genes of Proteus vulgaris isolated from tertiary care hospital, Islamabad, Pakistan.
    Bilal S; Anam S; Mahmood T; Abdullah RM; Nisar S; Kalsoom F; Luqman M; Anjum FR
    Pak J Pharm Sci; 2019 Nov; 32(6(Supplementary)):2887-2891. PubMed ID: 32024629
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The incidence and beta-lactam resistance of Proteus vulgaris in hospital infections: the last decade.
    Gomez-Alferez A; Baquero F; Canton R; Loza E; Martinez-Beltran J
    J Chemother; 1991 Oct; 3(5):283-8. PubMed ID: 1809807
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics and antibacterial efficacy in vivo of beta-lactam combinations against Proteus vulgaris.
    Dalhoff A; Gehl AE; Gau W; Lode H
    Chemotherapy; 1982; 28(6):444-53. PubMed ID: 6761080
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Induction of beta-lactamase in Proteus vulgaris.
    Okonogi K; Kuno M; Higashide E
    J Gen Microbiol; 1986 Jan; 132(1):143-50. PubMed ID: 3519851
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cefmenoxime (SCE-1365), a novel broad-spectrum cephalosporin: in vitro and in vivo antibacterial activities.
    Tsuchiya K; Kondo M; Kida M; Nakao M; Iwahi T; Nishi T; Noji Y; Takeuchi M; Nozaki Y
    Antimicrob Agents Chemother; 1981 Jan; 19(1):56-65. PubMed ID: 6941742
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inducer activity of beta-lactam antibiotics for the beta-lactamases of Proteus rettgeri and Proteus vulgaris.
    Yotsuji A; Minami S; Araki Y; Inoue M; Mitsuhashi S
    J Antibiot (Tokyo); 1982 Nov; 35(11):1590-3. PubMed ID: 6761329
    [No Abstract]   [Full Text] [Related]  

  • 14. Kinetic in vitro studies of antibacterial effects of the combination of new penicillins and cefalosporins against Proteus vulgaris.
    Dalhoff A; Gehl AE; Lode H
    Chemotherapy; 1982; 28(5):381-9. PubMed ID: 6754281
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of the in vitro and in vivo antibacterial activities of cefepime (BMY-28142) with ceftazidime, cefuzonam, cefotaxime and cefmenoxime.
    Masuyoshi S; Hiraoka M; Inoue M; Tomatsu K; Hirano M; Mitsuhashi S
    Drugs Exp Clin Res; 1989; 15(1):1-10. PubMed ID: 2663406
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Behaviour of cefmenoxime towards beta-lactamases.
    Labia R; Morand A; Ben Yaghlane H; Bryskier A
    Drugs Exp Clin Res; 1985; 11(6):373-8. PubMed ID: 3939122
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cefmenoxime. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.
    Campoli-Richards DM; Todd PA
    Drugs; 1987 Aug; 34(2):188-221. PubMed ID: 3304966
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Problems related to determination of MICs of oximino-type expanded-spectrum cephems for Proteus vulgaris.
    Ohno A; Ishii Y; Ma L; Yamaguchi K
    J Clin Microbiol; 2000 Feb; 38(2):677-81. PubMed ID: 10655366
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chromosomally encoded cephalosporin-hydrolyzing beta-lactamase of Proteus vulgaris RO104 belongs to Ambler's class A.
    Péduzzi J; Reynaud A; Baron P; Barthélémy M; Labia R
    Biochim Biophys Acta; 1994 Jul; 1207(1):31-9. PubMed ID: 8043607
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Enzymatic resistance to beta lactam antibiotics within the genus Proteus and evaluation of Proteus mirabilis phenotypes and genotypes for resistance to third- and fourth-generation cephalosporins].
    Rodríguez C; Radice M; Perazzi B; Castro S; Juárez J; Santini P; Vay C; Famiglietti A; Gutkind G
    Enferm Infecc Microbiol Clin; 2005 Mar; 23(3):122-6. PubMed ID: 15757582
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.